4r 12as N 2 4 Difluorobenzyl 7 Methoxy 4 Methyl 6 8 Dioxo 3 4 6 8 12 12a Hexahydro 2h 1 3 Oxazino 3 2 D Pyrido 1 2 A Pyrazine 9 Carboxamide
Fluorine Difluoride Fluorobenzene Fluorobenzyl Trifluorotoluene
(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
Chemical Name (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
Molecular Formula C20H18F2N4O5
Molecular Weight 432.38
Chemical Name (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
Molecular Formula C20H18F2N4O5
Molecular Weight 432.38
FAQ

What is the chemical structure of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyrazine-9-formamide?

This is a description of the chemical structure of an organic compound. According to the ancient style of Tiangong Kaiwu, it is as follows in the ancient saying:

There is a substance today, and its chemical structure is expressed as (4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] quinazolo [1,2-a] quinazole-9-formamide. Looking at this structure, it is like a delicate map. The atoms and groups, such as Yamagawa Chengguo, are arranged in an orderly manner according to specific rules.

Among them, (4R, 12aS) is the configuration mark of the chiral center, and the shape of the fixed molecule is three-dimensional. N- (2,4-difluorophenyl), just like a special town, the fluorine atom is like the elite in the town, attached to the phenyl group. 7-Methoxy group, in a specific position of the molecule, adds a combination of an oxygen group and a methyl group, just like a unique building in the city. 4-Methyl group, and elsewhere, adds a methyl group to increase the unique appearance of the molecule.

6,8-Dioxo, which replaces the hydrogen at a specific position for the dioxygen atom to form a special carbonyl structure, such as two important mansions in the city. 3,4,6,8,12,12a- hexahydro, indicating that the six unsaturated bonds are hydrogenated and saturated, which makes the skeleton of the molecule somewhat stable. 2H- [1,3] oxazino [3,2-d] quinazolo [1,2-a] quinazole, this is a thick heterocyclic system, interlocking, like a palace community in the city, with a complex and delicate structure. 9-Formamide, at a specific position, is decorated with formamide groups, adding a unique charm to the structure of the whole molecule, making its properties and uses unique.

What are the main uses of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyrazine-9-formamide?

(4R, 12aS) - N - (2,4 - difluorophenyl) - 7 - methoxy - 4 - methyl - 6,8 - dioxo - 3,4,6,8,12,12a - hexahydro - 2H - [1,3] oxazino [3,2 - d] pyrido [1,2 - a] pyrido - 9 - methanesulfonamide This substance has a critical use.

It is used in the field of medicine or as a good medicine for the treatment of specific diseases. The unique structure of the genome, containing difluorophenyl, methoxy and other groups, gives it the ability to bind to specific targets in organisms, or can regulate related physiological processes, which is helpful for the treatment of diseases. When developing new drugs, this compound may be a key active ingredient. With its characteristics, after rational modification and formulation, it is expected to make highly effective and low-toxicity drugs to fight against diseases such as inflammation, infection or nervous system.

It is also of great significance in the field of chemical research. Complex structures provide challenges and opportunities for organic synthetic chemistry. Chemists can study its synthesis path, optimize reaction conditions, explore novel synthesis methods, and promote the development of organic synthetic chemistry. Furthermore, the investigation of the relationship between its structure and activity may provide ideas for the design and synthesis of more potential compounds, paving the way for new drug development and materials science.

What is the pharmacological mechanism of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyrazine-9-formamide?

(4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyrimidine and [1,2-a] pyrimidine-9-formamide This drug is a delicate thing. Its pharmacological mechanism is quite complicated, just like the precision machine, which hides many mysteries.

Looking at its effectiveness, it can precisely fit specific targets in the body, just like the interlocking of mortise and tenon, a tight fit. This drug can be combined with specific proteins or receptors, just like a key to unlock, start or block a series of biochemical reaction pathways. Through this action, the growth, proliferation, differentiation and other processes of cells are regulated.

It may interfere with cell signaling, so that the "messenger" of transmission is orderly and not disordered; or it affects the activity of key enzymes, so that the rate and direction of biochemical reactions are smooth. All of these are the cornerstones of its pharmacological action, making it play a key role in the healing of diseases, in order to achieve the purpose of eliminating diseases and restoring health.

What are the side effects of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyrazine-9-formamide?

(4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyridine-9-formamide, the side effects of this substance are as follows:

First, it often affects the gastrointestinal tract. Taking it may cause nausea and vomiting, which is caused by the drug stimulating the gastrointestinal mucosa and enhancing gastrointestinal counter-peristalsis. It may also cause diarrhea, the drug interferes with the normal absorption and secretion function of the intestine, and the intestinal contents quickly pass through the intestine, and the water absorption is insufficient, resulting in diarrhea.

Second, it also has potential effects on liver function. Long-term or large-scale use, or the liver metabolic burden. The liver needs to transform and detoxify the drug. If the burden is too heavy, it may cause an increase in transaminase, which will affect the normal metabolism and synthesis of the liver, and then affect the overall body function.

Third, it also has an effect on the nervous system. Some people may feel dizzy and headache after taking it, because the drug affects the transmission of neurotransmitters in the nervous system or affects the diastolic and contractile functions of cerebrovascular vessels. In severe cases, it may cause insomnia, interfere with normal sleep rhythm, and affect the quality of life and daytime mental state.

Fourth, it may also affect the blood system. Or cause a decrease in the number of white blood cells and platelets, and reduce the body's immune and coagulation functions. Leukopenia decreases the body's ability to resist pathogens, making it susceptible to disease; thrombocytopenia hinders the coagulation mechanism, and minor injuries may also cause bleeding.

What is the market prospect of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyrazine-9-formamide?

Guanfu (4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyridino-9-formamide The market prospect of this product is related to many aspects, just like the change of celestial phenomena, which needs to be carefully examined.

The characteristics of this product have a unique structure, or it has extraordinary potential in the field of medicine and other fields. In today's world, the demand for medicine is like the dry seedling Panlin, and new compounds are often the key to breaking the situation. If it can demonstrate excellent pharmacological activity, just like a sword out of a box, it will surely attract the attention of all parties and win a place in the market.

Looking at the market landscape, the competition is as fierce as the competition between Chu and Han. However, opportunities also coexist, such as stars in the dark night, flickering to be seen. If developers can gain insight into opportunities, such as good gamers, plan games, preemptively layout production, optimize processes, reduce costs and increase efficiency, and are recognized by regulations, such as boats flowing downstream, they are expected to spread their wings like Dapeng, soar up and open up a broad market.

However, there are also challenges lying on the mountain. It is necessary to deal with the fierce enemies of peer competition, and it is also necessary to adapt to the changeable market demand. Just like sailing against the current, if you don't advance, you will retreat. And the huge cost of R & D and the long cycle are all obstacles to moving forward, just like the difficulty of Shu Dao, which is difficult to reach the sky.

To sum up, (4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- [1,3] oxazino [3,2-d] pyridino [1,2-a] pyridino-9-formamide The market prospect is like a change of clear clouds, which contains both the light of hope and the risk of unknown. Only with courage and wisdom can we stand at the forefront of the market and seek development.